Read more about Moderna expects $18.4 billion in coronavirus vaccine sales in 2021 on Business Standard. Moderna, whose shares rose 4 per cent to $150.7 in trading before the bell, has been aiming to ramp up production of the vaccine
Moderna Inc said on Thursday it expects Covid-19 vaccine sales of $18.4 billion this year, above the $15 billion in sales forecast by Pfizer Inc for the only other vaccine authorized for emergency use in the United States so far. Both vaccines, developed using a technology based on messenger RNA (mRNA), are being distributed at an unprecedented speed as cases mount in the United States, with deaths from Covid-19 surpassing the dire milestone of 500,000.
